Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00533650 | Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005) | PHASE2 | COMPLETED | 227 | — | — | Dec 1, 2000 | Oct 1, 2002 | Jul 29, 2016 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0429 | DRUG | - |
Inclusion Criteria: * Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis Exclusion Criteria: * Person has had a previous fracture * Person has rheumatoid arthritis. Person has has certain types of cancer * Person has donated blood or has been ...